Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandelli

Showing results (61-70 of 573) with videos related to

Pageof 58
Sort By:
Leukemia|December 9, 1998
Acute promyelocytic leukemia: a curable diseaseF Lo Coco, C Nervi, G Avvisati, et al.
Recenti Progressi in Medicina|April 1, 1978
[Autoimmune hemolytic manifestations associated with Hodgkin's disease]V Boccardi, G Girelli, A P Anselmo, et al.
Haematologica|March 1, 1995
The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemiaD Diverio, R Riccioni, F Mandelli, et al.
Haematologica|January 1, 1970
[Biochemistry of erythrocytes in acquired hemolytic anemias]F Mandelli, L Fontana, G Papa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1991
The F-MACHOP sequential combination chemotherapy regimen in advanced diffuse aggressive lymphomas: long-term resultsC Guglielmi, S Amadori, M Martelli, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1985
Serum bactericidal activity as a therapeutic guide in severely granulocytopenic patients with gram-negative septicemiaP Martino, M Venditti, B Valente, et al.
Infection|January 1, 1985
Superinfections during antimicrobial treatment with betalactam-aminoglycoside combinations in neutropenic patients with hematologic malignanciesP Serra, C Santini, M Venditti, et al.
Leukemia|October 1, 1995
Acute lymphoblastic leukemia in the elderly: results of two different treatment approaches in 49 patients during a 25-year periodA Ferrari, L Annino, S Crescenzi, et al.
Leukemia & Lymphoma|June 1, 1992
F-MACHOP in advanced aggressive lymphomaC Guglielmi, S Amadori, M Martelli, et al.
Leukemia|October 24, 2003
Reactivation of porphyria cutanea tarda as a possible side effect of Imatinib at high dosage in chronic myeloid leukemiaM Breccia, R Latagliata, I Carmosino, et al.
Pageof 58

Showing results (61-70 of 573) with videos related to

Sort By:
Pageof 58
Leukemia|December 9, 1998
Acute promyelocytic leukemia: a curable diseaseF Lo Coco, C Nervi, G Avvisati, et al.
Recenti Progressi in Medicina|April 1, 1978
[Autoimmune hemolytic manifestations associated with Hodgkin's disease]V Boccardi, G Girelli, A P Anselmo, et al.
Haematologica|March 1, 1995
The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemiaD Diverio, R Riccioni, F Mandelli, et al.
Haematologica|January 1, 1970
[Biochemistry of erythrocytes in acquired hemolytic anemias]F Mandelli, L Fontana, G Papa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1991
The F-MACHOP sequential combination chemotherapy regimen in advanced diffuse aggressive lymphomas: long-term resultsC Guglielmi, S Amadori, M Martelli, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1985
Serum bactericidal activity as a therapeutic guide in severely granulocytopenic patients with gram-negative septicemiaP Martino, M Venditti, B Valente, et al.
Infection|January 1, 1985
Superinfections during antimicrobial treatment with betalactam-aminoglycoside combinations in neutropenic patients with hematologic malignanciesP Serra, C Santini, M Venditti, et al.
Leukemia|October 1, 1995
Acute lymphoblastic leukemia in the elderly: results of two different treatment approaches in 49 patients during a 25-year periodA Ferrari, L Annino, S Crescenzi, et al.
Leukemia & Lymphoma|June 1, 1992
F-MACHOP in advanced aggressive lymphomaC Guglielmi, S Amadori, M Martelli, et al.
Leukemia|October 24, 2003
Reactivation of porphyria cutanea tarda as a possible side effect of Imatinib at high dosage in chronic myeloid leukemiaM Breccia, R Latagliata, I Carmosino, et al.
Pageof 58